| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |